Xenograft models of premalignant breast disease
- PMID: 14973383
- DOI: 10.1023/a:1009577811584
Xenograft models of premalignant breast disease
Abstract
Dysplastic and hyperplastic proliferative lesions with graded severity of atypia are recognized in a number of tissues and are generally suspected to be premalignant, that is to say at high risk for further progressing to carcinoma in situ and invasive cancer. However, few xenograft models of premalignancy for any organ site have been successfully developed. A good model of human premalignant breast disease would lead to lesions which resemble high risk human breast disease in xenografts and sporadically progress to invasive cancer with time. In this chapter the use of breast tissue pieces and epithelial cells for establishment of xenografts and the development of human breast epithelial cell lines that form premalignant xenograft lesions are described. MCF10AT cells not only form simple differentiated ducts which persist in xenografts and sporadically progress to carcinoma, but also form intermediate proliferative lesions resembling proliferative disease without atypia, atypical hyperplasia, and carcinoma in situ.
Similar articles
-
MCF10AT: a model for the evolution of cancer from proliferative breast disease.Am J Pathol. 1996 Jan;148(1):313-9. Am J Pathol. 1996. PMID: 8546221 Free PMC article.
-
17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.Anticancer Res. 2000 Mar-Apr;20(2B):1101-8. Anticancer Res. 2000. PMID: 10810403
-
Xenograft model of progressive human proliferative breast disease.J Natl Cancer Inst. 1993 Nov 3;85(21):1725-32. doi: 10.1093/jnci/85.21.1725. J Natl Cancer Inst. 1993. PMID: 8411256
-
Intraductal proliferations of the breast: a review of histologic criteria for atypical intraductal hyperplasia and ductal carcinoma in situ, including apocrine and papillary lesions.Ann Diagn Pathol. 1998 Apr;2(2):135-45. doi: 10.1016/s1092-9134(98)80051-8. Ann Diagn Pathol. 1998. PMID: 9845731 Review.
-
Histological and biological evolution of human premalignant breast disease.Endocr Relat Cancer. 2001 Mar;8(1):47-61. doi: 10.1677/erc.0.0080047. Endocr Relat Cancer. 2001. PMID: 11350726 Review.
Cited by
-
Progressive increase of glucose transporter-3 (GLUT-3) expression in estrogen-induced breast carcinogenesis.Clin Transl Oncol. 2013 Jan;15(1):55-64. doi: 10.1007/s12094-012-0882-3. Epub 2012 Oct 2. Clin Transl Oncol. 2013. PMID: 23054751 Free PMC article.
-
Proteome-wide profiling of the MCF10AT breast cancer progression model.PLoS One. 2010 Jun 9;5(6):e11030. doi: 10.1371/journal.pone.0011030. PLoS One. 2010. PMID: 20543960 Free PMC article.
-
The Chinese Herbal Formula Ruyan Neixiao Cream Inhibits Angiogenesis of Precancerous Breast Lesions via Regulation of Ras/Raf/MEK/ERK Signaling Pathway.Integr Cancer Ther. 2022 Jan-Dec;21:15347354211069397. doi: 10.1177/15347354211069397. Integr Cancer Ther. 2022. PMID: 35094593 Free PMC article.
-
CD44 alternative splicing senses intragenic DNA methylation in tumors via direct and indirect mechanisms.Nucleic Acids Res. 2021 Jun 21;49(11):6213-6237. doi: 10.1093/nar/gkab437. Nucleic Acids Res. 2021. PMID: 34086943 Free PMC article.
-
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.BMC Cancer. 2012 Oct 30;12:500. doi: 10.1186/1471-2407-12-500. BMC Cancer. 2012. PMID: 23110523 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical